Gene: DOCK1
Official Full Name: dedicator of cytokinesis 1provided by HGNC
Gene Summary: This gene encodes a member of the dedicator of cytokinesis protein family. Dedicator of cytokinesis proteins act as guanine nucleotide exchange factors for small Rho family G proteins. The encoded protein regulates the small GTPase Rac, thereby influencing several biological processes, including phagocytosis and cell migration. Overexpression of this gene has also been associated with certain cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38191 | DOCK1 Knockout cell line (HeLa) | Human | DOCK1 | 1:3~1:6 | Negative | Online Inquiry |
KO38192 | DOCK1 Knockout cell line (HCT 116) | Human | DOCK1 | 1:2~1:4 | Negative | Online Inquiry |
KO38193 | DOCK1 Knockout cell line (HEK293) | Human | DOCK1 | 1:3~1:6 | Negative | Online Inquiry |
KO38194 | DOCK1 Knockout cell line (A549) | Human | DOCK1 | 1:3~1:4 | Negative | Online Inquiry |
DOCK1 Gene Knockout Cell Lines represent a cutting-edge biological tool essential for the study of cellular processes and disease mechanisms. These cell lines have been engineered to specifically disrupt the DOCK1 gene, which encodes a protein that plays a critical role in regulating Rac1-dependent signaling pathways. By abolishing this gene, the cell lines allow researchers to observe the downstream effects of the loss of DOCK1 function, facilitating insights into cell migration, adhesion, and differentiation processes.
The mechanisms underlying DOCK1 function are pivotal in various cellular contexts, including immune response, cancer progression, and neuronal signaling. The DOCK1 protein acts as a guanine nucleotide exchange factor (GEF) for Rac GTPases, influencing cellular behaviors that are fundamental to both normal physiology and pathophysiological states. By utilizing our DOCK1 Gene Knockout Cell Lines, scientists can effectively study these pathways in a controlled environment, leading to a deeper understanding of their implications in health and disease.
In research and clinical settings, the knockdown of DOCK1 provides a significant advantage to elucidating the role of this gene in tumorigenesis and potential therapeutic interventions. Compared to traditional methods such as RNA interference, which may yield transient effects, our knockout cell lines offer a stable and reproducible model that allows for long-term studies and more robust experimental outcomes.
The unique selling point of our DOCK1 Gene Knockout Cell Lines lies in their versatility; they can be used across a variety of research areas, from oncology to cell biology, enabling researchers to not only validate their hypotheses but also to explore novel avenues for therapeutic development. This product is invaluable for academic research, drug discovery, and translational medicine.
With a commitment to excellence and innovation in biological tools, our company leverages decades of expertise in genetic engineering and cell line development. We are dedicated to providing high-quality, reliable products that support the advancement of scientific knowledge and therapeutic discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.